Loading...
Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
Yang, Zhe Zhang, Qi Wu, Xiaoqing Hao, Siyuan Hao, Xinbao Jones, Elizabeth Zhang, Yuxia Qiu, Jianming Xu, Liang
Yang, Zhe
Zhang, Qi
Wu, Xiaoqing
Hao, Siyuan
Hao, Xinbao
Jones, Elizabeth
Zhang, Yuxia
Qiu, Jianming
Xu, Liang
Citations
Altmetric:
Abstract
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the global coronavirus disease 2019 (COVID-19) pandemic, and the search for effective treatments has been limited. Furthermore, the rapid mutations of SARS-CoV-2 have posed challenges to existing vaccines and neutralizing antibodies, as they struggle to keep up with the increased viral transmissibility and immune evasion. However, there is hope in targeting the CD147-spike protein, which serves as an alternative point for the entry of SARS-CoV-2 into host cells. This protein has emerged as a promising therapeutic target for the development of drugs against COVID-19. Here, we demonstrate that the RNA-binding protein Human-antigen R (HuR) plays a crucial role in the post-transcriptional regulation of CD147 by directly binding to its 3′-untranslated region (UTR). We observed a decrease in CD147 levels across multiple cell lines upon HuR depletion. Furthermore, we identified that niclosamide can reduce CD147 by lowering the cytoplasmic translocation of HuR and reducing CD147 glycosylation. Moreover, our investigation revealed that SARS-CoV-2 infection induces an upregulation of CD147 in ACE2-expressing A549 cells, which can be effectively neutralized by niclosamide in a dose-dependent manner. Overall, our study unveils a novel regulatory mechanism of regulating CD147 through HuR and suggests niclosamide as a promising therapeutic option against COVID-19.
Description
Date
2023-07-18
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
CD147, RNA-binding protein, HuR, Niclosamide, SARS-CoV-2, Western blot
Citation
Yang, Z.; Zhang, Q.; Wu, X.; Hao, S.; Hao, X.; Jones, E.; Zhang, Y.; Qiu, J.; Xu, L. Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147. Biomedicines 2023, 11, 2019. https://doi.org/10.3390/biomedicines11072019